Comparison of periodontal ligament and gingiva-derived mesenchymal stem cells for regenerative therapies
- 508 Downloads
Tissue-engineering therapies using undifferentiated mesenchymal cells (MSCs) from intra-oral origin have been tested in experimental animals. This experimental study compared the characteristics of undifferentiated mesenchymal stem cells from either periodontal ligament or gingival origin, aiming to establish the basis for the future use of these cells on regenerative therapies.
Materials and methods
Gingiva-derived mesenchymal stem cells (GMSCs) were obtained from de-epithelialized gingival biopsies, enzymatically digested and expanded in conditions of exponential growth. Their growth characteristics, phenotype, and differentiation ability were compared with those of periodontal ligament-derived mesenchymal stem cells (PDLMSCs).
Both periodontal ligament- and gingiva-derived cells displayed a MSC-like phenotype and were able to differentiate into osteoblasts, chondroblasts, and adipocytes. These cells were genetically stable following in vitro expansion and did not generate tumors when implanted in immunocompromised mice. Furthermore, under suboptimal growth conditions, GMSCs proliferated with higher rates than PDLMSCs.
Stem cells derived from gingival biopsies represent bona fide MSCs and have demonstrated genetic stability and lack of tumorigenicity.
Gingiva-derived MSCs may represent an accessible source of messenchymal stem cells to be used in future periodontal regenerative therapies.
KeywordsMesenchymal stem cells Tissue engineering Periodontal ligament Gingival Periodontal regeneration
We would like to thank the CIB FACS and animal facilities, Dr. C. Bernabeu (CIB-CSIC) and the Developmental Studies Hybridoma Bank, Iowa University, for P4A4mAb. The work carried out in the author’s laboratories received financing from the Spanish Ministry of Health (EC10-095) and the Osteology Foundation (#10-063) to MS, and Instituto de Salud Carlos III (RD06/0010/1010) to JAGS. NS was the recipient of a FPU fellowship (AP2009-3682).
Compliance with ethical standards
Conflict of interest
Author Silvia Santamaria declares that she has no conflict of interest. Author Nerea Sanchez declares that she has no conflict of interest. Author Mariano Sanz declares that he has no conflict of interest. Author Jose A. Garcia-Sanz declares that he has no conflict of interest. All the authors declare that they had full control of all primary data and agree to allow the Journal to review it if requested.
The work carried out in the author’s laboratories received financing from the Spanish Ministry of Health (EC10-095) and the Osteology Foundation (#10-063) to MS, and Instituto de Salud Carlos III (RD06/0010/1010) to JAGS. NS was the recipient of a FPU fellowship (AP2009-3682).
All human studies have been approved by the Universidad Complutense de Madrid ethics committee for Clinical Research and have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its latter amendments. The Universidad Complutense de Madrid bioethics committee approved the experimental protocols involving animals. The experiments involving animals have been carried following the appropriate EU and Spanish national laws.
All persons gave their informed consent prior to their inclusion in the study by signing an IRB-approved informed consent.
- 5.Sanz M, Tonetti MS, Zabalegui I, Sicilia A, Blanco J, Rebelo H, Rasperini G, Merli M, Cortellini P, Suvan JE (2004) Treatment of intrabony defects with enamel matrix proteins or barrier membranes: results from a multicenter practice-based clinical trial. J Periodontol 75(5):726–733. doi: 10.1902/jop.2004.75.5.726 CrossRefPubMedGoogle Scholar
- 10.Nunez J, Sanz-Blasco S, Vignoletti F, Munoz F, Arzate H, Villalobos C, Nunez L, Caffesse RG, Sanz M (2012) Periodontal regeneration following implantation of cementum and periodontal ligament-derived cells. J Periodontal Res 47(1):33–44. doi: 10.1111/j.1600-0765.2011.01402.x CrossRefPubMedGoogle Scholar
- 12.Tomic S, Djokic J, Vasilijic S, Vucevic D, Todorovic V, Supic G, Colic M (2011) Immunomodulatory properties of mesenchymal stem cells derived from dental pulp and dental follicle are susceptible to activation by toll-like receptor agonists. Stem Cells Dev 20(4):697–708. doi: 10.1089/scd.2010.0145 CrossRefGoogle Scholar
- 14.Morsczeck C, Vollner F, Saugspier M, Brandl C, Reichert TE, Driemel O, Schmalz G (2010) Comparison of human dental follicle cells (DFCs) and stem cells from human exfoliated deciduous teeth (SHED) after neural differentiation in vitro. Clin Oral Investig 14(4):433–440. doi: 10.1007/s00784-009-0310-4 CrossRefPubMedGoogle Scholar
- 18.Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315–317. doi: 10.1080/14653240600855905 CrossRefPubMedGoogle Scholar
- 19.Tomar GB, Srivastava RK, Gupta N, Barhanpurkar AP, Pote ST, Jhaveri HM, Mishra GC, Wani MR (2010) Human gingiva-derived mesenchymal stem cells are superior to bone marrow-derived mesenchymal stem cells for cell therapy in regenerative medicine. Biochem Biophys Res Commun 393(3):377–383. doi: 10.1016/j.bbrc.2010.01.126 CrossRefPubMedGoogle Scholar
- 26.Tsumanuma Y, Iwata T, Washio K, Yoshida T, Yamada A, Takagi R, Ohno T, Lin K, Yamato M, Ishikawa I, Okano T, Izumi Y (2011) Comparison of different tissue-derived stem cell sheets for periodontal regeneration in a canine 1-wall defect model. Biomaterials 32(25):5819–5825. doi: 10.1016/j.biomaterials.2011.04.071 CrossRefPubMedGoogle Scholar
- 28.Fujita T, Iwata T, Shiba H, Igarashi A, Hirata R, Takeda K, Mizuno N, Tsuji K, Kawaguchi H, Kato Y, Kurihara H (2007) Identification of marker genes distinguishing human periodontal ligament cells from human mesenchymal stem cells and human gingival fibroblasts. J Periodontal Res 42(3):283–286. doi: 10.1111/j.1600-0765.2006.00944.x CrossRefPubMedGoogle Scholar
- 31.Zhang Q, Shi S, Liu Y, Uyanne J, Shi Y, Le AD (2009) Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. J Immunol 183(12):7787–7798. doi: 10.4049/jimmunol.0902318 CrossRefPubMedPubMedCentralGoogle Scholar
- 35.Zhang QZ, Su WR, Shi SH, Wilder-Smith P, Xiang AP, Wong A, Nguyen AL, Kwon CW, Le AD (2010) Human gingiva-derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing. Stem Cells 28(10):1856–1868. doi: 10.1002/stem.503 CrossRefPubMedPubMedCentralGoogle Scholar
- 43.Fawzy El-Sayed KM, Paris S, Becker ST, Neuschl M, De Buhr W, Salzer S, Wulff A, Elrefai M, Darhous MS, El-Masry M, Wiltfang J, Dorfer CE (2012) Periodontal regeneration employing gingival margin-derived stem/progenitor cells: an animal study. J Clin Periodontol 39(9):861–870. doi: 10.1111/j.1600-051X.2012.01904.x CrossRefPubMedGoogle Scholar
- 46.Zhang Q, Nguyen AL, Shi S, Hill C, Wilder-Smith P, Krasieva TB, Le AD (2012) Three-dimensional spheroid culture of human gingiva-derived mesenchymal stem cells enhances mitigation of chemotherapy-induced oral mucositis. Stem Cells Dev 21(6):937–947. doi: 10.1089/scd.2011.0252 CrossRefPubMedGoogle Scholar